CONNECT WITH US
Fintech

Fintech

Turtlemint Crashes Another 20%, PB Fintech Falls 8% On IRDAI’s Proposed Commission Caps

Inc42 – Fintech logo

Published on

Add as a preferred source on Google
Turtlemint Crashes Another 20%, PB Fintech Falls 8% On IRDAI’s Proposed Commission Caps

The sell-off in insurtech stocks continued for the second straight session today as the Insurance Regulatory and Development Authority of India’s (IRDAI) proposed overhaul of insurance distribution commissions rattled investors. 

Shares of Policybazaar parent PB Fintech fell as much as 7.8% to touch a fresh 52-week low of ₹1,115.10 on the BSE. Meanwhile, Turtlemint shares opened at their 20% lower circuit of ₹87.30, which was also the stock’s fresh all-time low.

The stocks later pared some of their losses. At 12:21 IST, PB Fintech was trading 5.12% lower at ₹1,148.10, with a market capitalisation of ₹53,128.6 Cr (about $5.5 Bn).

Turtlemint was trading 18.84% lower at ₹88.55, giving the insurtech company a market capitalisation of ₹2,607.6 Cr (about $272 Mn).

At the prevailing prices, PB Fintech shares have fallen about 39% across the two sessions, while Turtlemint has declined about 35% from its level before the sell-off began.

The rout began yesterday after IRDAI released a consultation paper proposing product- and channel-specific commission ceilings for insurance distributors. The proposed framework would reintroduce product-level commission caps more than three years after the regulator removed such limits in April 2023 and shifted to an expenses of management (EoM) framework. 

Under the proposed framework, commissions for insurance distributors would vary based on the product, distribution channel and effort involved in selling and servicing a policy. Open-architecture insurance distribution entities such as Policybazaar and Turtlemint’s insurance broking arm would generally face lower caps than individual agents and other distributors.

For digital insurance distributors, the proposed changes could put pressure on revenue from health, motor and life insurance, while forcing platforms to rethink customer acquisition costs and sales incentives.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.